140 related articles for article (PubMed ID: 26114761)
21. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J
BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030
[TBL] [Abstract][Full Text] [Related]
22. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Significant Carotid Stenosis for Nasopharyngeal Carcinoma between Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy.
Liao W; Zhou H; Fan S; Zheng Y; Zhang B; Zhao Z; Xiao S; Bai S; Liu J
Sci Rep; 2018 Sep; 8(1):13899. PubMed ID: 30224668
[TBL] [Abstract][Full Text] [Related]
24. Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Kuang WL; Zhou Q; Shen LF
Clin Transl Oncol; 2012 Oct; 14(10):783-90. PubMed ID: 22855156
[TBL] [Abstract][Full Text] [Related]
25. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
Qiu WZ; Peng XS; Xia HQ; Huang PY; Guo X; Cao KJ
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1563-1572. PubMed ID: 28342002
[TBL] [Abstract][Full Text] [Related]
26. Acute toxicity in nasopharyngeal carcinoma patients treated with IMRT/VMAT.
Ozdemir S; Akin M; Coban Y; Yildirim C; Uzel O
Asian Pac J Cancer Prev; 2015; 16(5):1897-900. PubMed ID: 25773841
[TBL] [Abstract][Full Text] [Related]
27. Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT.
Hsin CH; Tseng HC; Lin HP; Chen TH
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):471-7. PubMed ID: 25634060
[TBL] [Abstract][Full Text] [Related]
28. The clinical characteristics of secondary primary tumors in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy: A retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X; Wang X
Medicine (Baltimore); 2016 Nov; 95(45):e5364. PubMed ID: 27828863
[TBL] [Abstract][Full Text] [Related]
29. Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Lin L; Zhang WJ; Peng YL; Chen L; Tang LL; Mao YP; Ma J; Sun Y
Sci Rep; 2015 Sep; 5():13525. PubMed ID: 26323586
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.
Lee N; Harris J; Garden AS; Straube W; Glisson B; Xia P; Bosch W; Morrison WH; Quivey J; Thorstad W; Jones C; Ang KK
J Clin Oncol; 2009 Aug; 27(22):3684-90. PubMed ID: 19564532
[TBL] [Abstract][Full Text] [Related]
31. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
[TBL] [Abstract][Full Text] [Related]
32. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
33. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397
[TBL] [Abstract][Full Text] [Related]
34. Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy.
Mao YP; Zhou GQ; Liu LZ; Guo R; Sun Y; Li L; Lin AH; Zeng MS; Kang TB; Jia WH; Shao JY; Mai HQ; Ma J
Br J Cancer; 2014 May; 110(11):2633-9. PubMed ID: 24809780
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
36. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients.
Yu YH; Xia WX; Shi JL; Ma WJ; Li Y; Ye YF; Liang H; Ke LR; Lv X; Yang J; Xiang YQ; Guo X
Chin J Cancer; 2016 Jun; 35(1):59. PubMed ID: 27357728
[TBL] [Abstract][Full Text] [Related]
37. Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.
Su SF; Huang SM; Han F; Huang Y; Chen CY; Xiao WW; Sun XM; Lu TX
Radiat Oncol; 2013 Jan; 8():17. PubMed ID: 23336282
[TBL] [Abstract][Full Text] [Related]
38. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
[TBL] [Abstract][Full Text] [Related]
39. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
[TBL] [Abstract][Full Text] [Related]
40. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
